Literature DB >> 16107950

Effects of HIV-1 serostatus, HIV-1 RNA concentration, and CD4 cell count on the incidence of malaria infection in a cohort of adults in rural Malawi.

Padmaja Patnaik1, Charles S Jere, William C Miller, Irving F Hoffman, Jack Wirima, Richard Pendame, Steven R Meshnick, Terrie E Taylor, Malcolm E Molyneux, James G Kublin.   

Abstract

BACKGROUND: To assess the effects of human immunodeficiency virus (HIV) infection on susceptibility to malaria, we compared the incidence rates of malaria by HIV type 1 (HIV-1) serostatus, baseline blood HIV-1 RNA concentration, and baseline CD4 cell count, over the course of a malaria season.
METHODS: We followed a cohort of 349 adults in Malawi. For the 224 HIV-1-seropositive adults (64% of the cohort), we measured HIV-1 RNA concentration (n=187) and CD4 cell count (n=184) at baseline. Parasitemia was defined as presence of asexual parasites on a thick film of blood and was treated with sulfadoxine/pyrimethamine (SP), in accordance with national policy. Hazard ratios (HRs) of parasitemia were estimated using Cox regression. Demographics were adjusted for.
RESULTS: HIV-1 seropositivity was associated with parasitemia (adjusted HR, 1.8 [95% confidence interval {CI}, 1.2-2.7] for a first parasitemia episode; adjusted HR, 2.5 [95% CI, 1.5-4.2] for a second parasitemia episode [> 14 days after the first episode]; adjusted HR, 1.9 [95% CI, 1.4-2.6] for parasitemia overall). Treatment failure (parasitemia < or = 14 days after SP treatment) did not differ by HIV-1 serostatus (risk ratio, 1.3 [95% CI, 0.5-3.2]). HIV-1 RNA concentrations and CD4 cell counts were moderately but inconsistently associated with parasitemia. A high parasite density with fever was associated with HIV-1 seropositivity and low CD4 cell count.
CONCLUSION: HIV-infected adults in malaria-endemic areas are at increased risk for malaria. Where possible, additional malaria prevention efforts should be targeted at this population.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16107950     DOI: 10.1086/432730

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  58 in total

1.  The Interaction between HIV and malaria in Africa.

Authors:  Miriam K Laufer; Christopher V Plowe
Journal:  Curr Infect Dis Rep       Date:  2007-01       Impact factor: 3.725

2.  Providing insecticide treated bed nets in antiretroviral treatment clinics in Malawi: a pilot study.

Authors:  Sd Makombe; Dw Lowrance; K Kamoto; S Kabuluzi; J Zoya; Ej Schouten; K Bizuneh; Ad Harries
Journal:  Malawi Med J       Date:  2007-09       Impact factor: 0.875

3.  Malaria parasitemia and CD4 T cell count, viral load, and adverse HIV outcomes among HIV-infected pregnant women in Tanzania.

Authors:  Molly F Franke; Donna Spiegelman; Amara Ezeamama; Said Aboud; Gernard I Msamanga; Saurabh Mehta; Wafaie W Fawzi
Journal:  Am J Trop Med Hyg       Date:  2010-04       Impact factor: 2.345

4.  An In Vitro Model for Measuring Immune Responses to Malaria in the Context of HIV Co-infection.

Authors:  Constance Finney; Lena Serghides
Journal:  J Vis Exp       Date:  2015-10-06       Impact factor: 1.355

Review 5.  Parasite virulence, co-infections and cytokine balance in malaria.

Authors:  Raquel Müller Gonçalves; Nathália Ferreira Lima; Marcelo Urbano Ferreira
Journal:  Pathog Glob Health       Date:  2014-05-23       Impact factor: 2.894

6.  Human immunodeficiency virus co-infection increases placental parasite density and transplacental malaria transmission in Western Kenya.

Authors:  Steven D Perrault; Jan Hajek; Kathleen Zhong; Simon O Owino; Moses Sichangi; Geoffrey Smith; Ya Ping Shi; Julie M Moore; Kevin C Kain
Journal:  Am J Trop Med Hyg       Date:  2009-01       Impact factor: 2.345

Review 7.  Immunomodulation in Plasmodium falciparum malaria: experiments in nature and their conflicting implications for potential therapeutic agents.

Authors:  Anne E P Frosch; Chandy C John
Journal:  Expert Rev Anti Infect Ther       Date:  2012-11       Impact factor: 5.091

8.  Update on the efficacy, effectiveness and safety of artemether-lumefantrine combination therapy for treatment of uncomplicated malaria.

Authors:  Pauline Byakika-Kibwika; Mohammed Lamorde; Harriet Mayanja-Kizza; Concepta Merry; Bob Colebunders; Jean-Pierre Van Geertruyden
Journal:  Ther Clin Risk Manag       Date:  2010-02-02       Impact factor: 2.423

Review 9.  Over-diagnosis and co-morbidity of severe malaria in African children: a guide for clinicians.

Authors:  Samson Gwer; Charles R J C Newton; James A Berkley
Journal:  Am J Trop Med Hyg       Date:  2007-12       Impact factor: 2.345

10.  Altered immune responses in rhesus macaques co-infected with SIV and Plasmodium cynomolgi: an animal model for coincident AIDS and relapsing malaria.

Authors:  Jeffrey W Koehler; Michael Bolton; Amanda Rollins; Kirsten Snook; Eileen deHaro; Elizabeth Henson; Linda Rogers; Louis N Martin; Donald J Krogstad; Mark A James; Janet Rice; Billie Davison; Ronald S Veazey; Ramesh Prabhu; Angela M Amedee; Robert F Garry; Frank B Cogswell
Journal:  PLoS One       Date:  2009-09-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.